Superworth

PharmaCyte Biotech EPS PMCB

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jul 31, 2026
−$2.40
Latest quarter, Q1 FY27
−$0.54
Fiscal year 2026
−$3.09
−231% on the year before

PharmaCyte Biotech's earnings per share was −$2.40 over the twelve months to Jul 31, 2026.

In its latest quarter, Q1 FY27, it was −$0.54.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$3.09−231%
FY2025$2.35n/a
FY2024−$1.76n/a
FY2023−$0.21n/a
FY2022−$0.81n/a
FY2021−$2.51n/a
FY2020$0.00n/a
FY2019$0.00n/a
FY2018$0.00n/a
FY2017$0.00n/a
FY2016$0.00n/a
FY2015−$31.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q1 FY27−$0.54n/a−$2.40
Q4 FY26−$0.45−135%−$3.09
Q3 FY26−$0.17n/a−$1.36
Q2 FY26−$1.24n/a−$1.63
Q1 FY26−$1.23−165%−$0.78
Q4 FY25$1.28n/a$2.35
Q3 FY25−$0.44n/a$0.76
Q2 FY25−$0.39n/a$0.55
Q1 FY25$1.90n/a$0.68
Q4 FY24−$0.31n/a−$1.76
Q3 FY24−$0.65n/a−$1.46
Q2 FY24−$0.26n/a−$0.85

Against its peers

Companies in Healthcare nearest PharmaCyte Biotech's size, closest first, today.

CompanyEPS, 12 monthsGrowth
PMCBPharmaCyte Biotech−$2.40
OXBROXBRIDGE RE HOLDINGS$0.02
EDUCEducational Development$0.19
GTIMGood Times Restaurants$0.21+75% a year
MDRRMedalist Diversified$3.84
BCGBinah Capital$0.16
VIPVulcan Infrastructure & Power$0.07
MXCMexco Energy$0.75−5% a year
CKXCKX Lands$1.42+647% a year
MSGMMotorsport Games$0.43+187% a year
ATCHAtlasClear$0.01
Peer median$0.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on PharmaCyte Biotech

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.